Alpha-blocker therapy does not decrease the risk for prostate cancer death, but it is associated with an elevated risk for low-grade prostate cancer. Preclinical studies have suggested that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback